Conference abstract · 18 Nov 2025
Conference abstractPublished 25 Jul 2024
Distribution of Viral Hepatitis and effect on outcome in liver transplant recipients -Georgian experience
University of Georgia/Batumi Shota Rustaveli State University, Georgia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background and Aims: Viral hepatitis are a major cause of liver disease worldwide, an estimated 354 million people worldwide live with hepatitis B or C, and for most, testing and treatment remain beyond reach and hepatitis B and C are the most common causes of chronic liver disease and liver transplantation. Current therapeutic approaches are far from optimal, and Liver transplantation is the only alternative for patients with end-stage liver disease.10 years ago Eastern European country Georgia has started liver transplantation and we faced challenges such as limited healthcare funding, insufficient infrastructure, late appeal and Low level of consciousness about hepatitis. The aim of the paper is to describe distribution and Liver Transplantation outcome among Recipients with viral hepatitis. Methods: The study used cross sectional data analysis to answer the research question. Information on interesting variables was obtained from the medical documentations of patients’ medical history in Batumi Transplant Center. Study subjects were adult liver recipients who had liver transplantation since 2014, a totally 95 patients and were under regular follow-up, including criteria was positive viral hepatitis. Analysis was performed using SPSS (23.0) and This study was approved by the ethical committee at Batumi Referral Hospital. Results: According to secondary analysis of medical cards of liver transplant recipients in our center show that totally 73 Recipients 15 Female and 58 Male were positive on Viral hepatitis, out of them 47 (32%) were HCV positive, 12 (9%) were HBV positive, 7 (5,1%) recipients were positive on HBV and HDV viruses and 7 (5.1%) recipients were positive on HCV and HBV viruses. By using crosstab analyze we could not find independently which type of Viral Hepatitis has a significant effect on outcome but highest mortality rate is shown in recipients with hepatitis B 58,3%. Conclusions: After liver transplantation, individuals with a history of viral hepatitis require lifelong monitoring and management. This includes regular follow-up visits, monitoring for signs of viral recurrence, and, if necessary, adjusting antiviral medications to prevent graft damage. Overall, liver transplantation plays a crucial role in the management of end-stage liver disease due to viral hepatitis. Advances in antiviral therapy and transplantation techniques advancements in antiviral therapy, perioperative management, and post-transplant care have led to significant improvements in survival rates for patients with viral hepatitis undergoing liver transplantation. However, close monitoring and lifelong management are essential to prevent disease recurrence and optimize long-term outcomes.
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.
More from this journal
The newest in Journal of Hepatology and Gastrointestinal disorders.
Conference abstract · 18 Nov 2025
Health benefits of probiotic bacteria
Conference abstract · 18 Nov 2025
Comprehensive case study of periampullary carcinoma in a 70-year-old patient: Management, nursing interventions, and recovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Hepatology and Gastrointestinal disorders
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Marika Mortuladze”
